HEADER OXIDOREDUCTASE 12-AUG-08 2W0A TITLE CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1- TITLE 2 (PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 51; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYP51, CYPLI, P450-LIA1, STEROL 14-ALPHA DEMETHYLASE, COMPND 5 LANOSTEROL 14-ALPHA DEMETHYLASE, P450-14DM; COMPND 6 EC: 1.14.13.70; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: 4XHIS TAG AT THE C-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HMS174(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS STEROID BIOSYNTHESIS, PROTEIN-INHIBITOR COMPLEX, METAL-BINDING, KEYWDS 2 OXIDOREDUCTASE, LIPID SYNTHESIS, NADP, IRON, HEME, CYTOPLASM, KEYWDS 3 MONOOXYGENASE, STEROL BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR L.M.PODUST REVDAT 4 13-DEC-23 2W0A 1 REMARK LINK REVDAT 3 08-MAY-19 2W0A 1 REMARK REVDAT 2 10-FEB-09 2W0A 1 JRNL REMARK REVDAT 1 20-JAN-09 2W0A 0 JRNL AUTH C.-K.CHEN,P.S.DOYLE,L.V.YERMALITSKAYA,Z.B.MACKEY,K.K.H.ANG, JRNL AUTH 2 J.H.MCKERROW,L.M.PODUST JRNL TITL TRYPANOSOMA CRUZI CYP51 INHIBITOR DERIVED FROM A JRNL TITL 2 MYCOBACTERIUM TUBERCULOSIS SCREEN HIT. JRNL REF PLOS NEGL TROP DIS V. 3 E372 2009 JRNL REFN ISSN 1935-2727 JRNL PMID 19190730 JRNL DOI 10.1371/JOURNAL.PNTD.0000372 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 48261 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5377 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2736 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.18 REMARK 3 BIN R VALUE (WORKING SET) : 0.1780 REMARK 3 BIN FREE R VALUE SET COUNT : 312 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3361 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 285 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.15000 REMARK 3 B22 (A**2) : -1.17000 REMARK 3 B33 (A**2) : -0.97000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.162 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.110 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.060 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.690 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3551 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4817 ; 1.449 ; 2.003 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 424 ; 5.603 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 176 ;31.453 ;22.784 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 568 ;13.271 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;16.507 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 505 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2778 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2120 ; 1.199 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3394 ; 1.908 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1431 ; 2.888 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1423 ; 4.054 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3551 ; 1.968 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 285 ; 5.780 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3463 ; 3.141 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES 1-2, 90-105, 217-221, 235-236 ARE DISORDERED REMARK 3 DISORDERED REGIONS WERE OMITTED FROM THE STRUCTURE REMARK 4 REMARK 4 2W0A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1290037189. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI (220) DOUBLE CRYSTAL REMARK 200 OPTICS : SAGITTAL FOCUSING CRYSTAL AND REMARK 200 VERTICALLY FOCUSING DOUBLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53704 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.01000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 32.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1X8V REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 4000, 2% ISOPROPANOL, 0.1 M REMARK 280 HEPES, PH=7.5, T=23 C, PH 7.5, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.37250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.47450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.83100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.47450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.37250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.83100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 37 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 442 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ASP A 90 REMARK 465 ALA A 91 REMARK 465 SER A 92 REMARK 465 PRO A 93 REMARK 465 GLU A 94 REMARK 465 ARG A 95 REMARK 465 ARG A 96 REMARK 465 LYS A 97 REMARK 465 GLU A 98 REMARK 465 MET A 99 REMARK 465 LEU A 100 REMARK 465 HIS A 101 REMARK 465 ASN A 102 REMARK 465 ALA A 103 REMARK 465 ALA A 104 REMARK 465 LEU A 105 REMARK 465 PRO A 217 REMARK 465 THR A 218 REMARK 465 ASP A 219 REMARK 465 LYS A 220 REMARK 465 SER A 221 REMARK 465 GLU A 235 REMARK 465 THR A 236 REMARK 465 VAL A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 HIS A 455 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 85 CG CD OE1 OE2 REMARK 470 VAL A 87 CG1 CG2 REMARK 470 VAL A 88 CG1 CG2 REMARK 470 ASP A 222 CG OD1 OD2 REMARK 470 ARG A 391 CG CD NE CZ NH1 NH2 REMARK 470 GLY A 450 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2209 O HOH A 2210 1.93 REMARK 500 CG GLU A 331 NH2 ARG A 338 2.03 REMARK 500 ND1 HIS A 392 O1D HEM A 470 2.11 REMARK 500 O HOH A 2047 O HOH A 2207 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 46 -125.46 50.35 REMARK 500 GLN A 375 58.31 31.97 REMARK 500 ASN A 380 67.43 -105.56 REMARK 500 THR A 449 -116.04 -95.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 NONE (C11): COORDINATION BOND TO THE HEME IRON REMARK 600 PROTOPORPHYRIN IX CONTAINING FE (HEM): THIOLATE BOND TO CYS REMARK 600 A 394 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 470 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 394 SG REMARK 620 2 HEM A 470 NA 91.7 REMARK 620 3 HEM A 470 NB 87.1 91.4 REMARK 620 4 HEM A 470 NC 87.4 178.7 89.5 REMARK 620 5 HEM A 470 ND 94.8 86.9 177.4 92.3 REMARK 620 6 CII A1450 N1 175.5 88.6 88.4 92.3 89.7 REMARK 620 7 CII A1450 N1 177.2 86.6 90.7 94.3 87.2 3.1 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 470 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CII A1450 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BZ9 RELATED DB: PDB REMARK 900 LIGAND-FREE STRUCTURE OF STEROL 14ALPHA- DEMETHYLASE FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP REMARK 900 RELATED ID: 1U13 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T /C442A-TRIPLEMUTANT OF REMARK 900 CYP51 FROM MYCOBACTERIUM TUBERCULOSIS REMARK 900 RELATED ID: 2CI0 RELATED DB: PDB REMARK 900 HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED REMARK 900 EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS REMARK 900 RELATED ID: 2CIB RELATED DB: PDB REMARK 900 HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED REMARK 900 EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS REMARK 900 RELATED ID: 1E9X RELATED DB: PDB REMARK 900 CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE ( CYP51) FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE REMARK 900 RELATED ID: 1X8V RELATED DB: PDB REMARK 900 ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- REMARK 900 DEMETHYLASE (CYP51) REMARK 900 RELATED ID: 2VKU RELATED DB: PDB REMARK 900 4,4'-DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING REMARK 900 SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE REMARK 900 OF THE COMPLEX REMARK 900 RELATED ID: 1H5Z RELATED DB: PDB REMARK 900 CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE ( CYP51) FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE REMARK 900 RELATED ID: 1EA1 RELATED DB: PDB REMARK 900 CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE ( CYP51) FROM REMARK 900 MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE REMARK 900 RELATED ID: 2W09 RELATED DB: PDB REMARK 900 CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR REMARK 900 RELATED ID: 2W0B RELATED DB: PDB REMARK 900 CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATIONS C37L, C442A ENGINEERED 4XHIS TAG AT THE C- REMARK 999 TERMINUS DBREF 2W0A A 1 451 UNP P0A512 CP51_MYCTU 1 451 DBREF 2W0A A 452 455 PDB 2W0A 2W0A 452 455 SEQADV 2W0A LEU A 37 UNP P0A512 CYS 37 ENGINEERED MUTATION SEQADV 2W0A ALA A 86 UNP P0A512 GLY 86 CONFLICT SEQADV 2W0A ALA A 442 UNP P0A512 CYS 442 ENGINEERED MUTATION SEQRES 1 A 455 MET SER ALA VAL ALA LEU PRO ARG VAL SER GLY GLY HIS SEQRES 2 A 455 ASP GLU HIS GLY HIS LEU GLU GLU PHE ARG THR ASP PRO SEQRES 3 A 455 ILE GLY LEU MET GLN ARG VAL ARG ASP GLU LEU GLY ASP SEQRES 4 A 455 VAL GLY THR PHE GLN LEU ALA GLY LYS GLN VAL VAL LEU SEQRES 5 A 455 LEU SER GLY SER HIS ALA ASN GLU PHE PHE PHE ARG ALA SEQRES 6 A 455 GLY ASP ASP ASP LEU ASP GLN ALA LYS ALA TYR PRO PHE SEQRES 7 A 455 MET THR PRO ILE PHE GLY GLU ALA VAL VAL PHE ASP ALA SEQRES 8 A 455 SER PRO GLU ARG ARG LYS GLU MET LEU HIS ASN ALA ALA SEQRES 9 A 455 LEU ARG GLY GLU GLN MET LYS GLY HIS ALA ALA THR ILE SEQRES 10 A 455 GLU ASP GLN VAL ARG ARG MET ILE ALA ASP TRP GLY GLU SEQRES 11 A 455 ALA GLY GLU ILE ASP LEU LEU ASP PHE PHE ALA GLU LEU SEQRES 12 A 455 THR ILE TYR THR SER SER ALA CYS LEU ILE GLY LYS LYS SEQRES 13 A 455 PHE ARG ASP GLN LEU ASP GLY ARG PHE ALA LYS LEU TYR SEQRES 14 A 455 HIS GLU LEU GLU ARG GLY THR ASP PRO LEU ALA TYR VAL SEQRES 15 A 455 ASP PRO TYR LEU PRO ILE GLU SER PHE ARG ARG ARG ASP SEQRES 16 A 455 GLU ALA ARG ASN GLY LEU VAL ALA LEU VAL ALA ASP ILE SEQRES 17 A 455 MET ASN GLY ARG ILE ALA ASN PRO PRO THR ASP LYS SER SEQRES 18 A 455 ASP ARG ASP MET LEU ASP VAL LEU ILE ALA VAL LYS ALA SEQRES 19 A 455 GLU THR GLY THR PRO ARG PHE SER ALA ASP GLU ILE THR SEQRES 20 A 455 GLY MET PHE ILE SER MET MET PHE ALA GLY HIS HIS THR SEQRES 21 A 455 SER SER GLY THR ALA SER TRP THR LEU ILE GLU LEU MET SEQRES 22 A 455 ARG HIS ARG ASP ALA TYR ALA ALA VAL ILE ASP GLU LEU SEQRES 23 A 455 ASP GLU LEU TYR GLY ASP GLY ARG SER VAL SER PHE HIS SEQRES 24 A 455 ALA LEU ARG GLN ILE PRO GLN LEU GLU ASN VAL LEU LYS SEQRES 25 A 455 GLU THR LEU ARG LEU HIS PRO PRO LEU ILE ILE LEU MET SEQRES 26 A 455 ARG VAL ALA LYS GLY GLU PHE GLU VAL GLN GLY HIS ARG SEQRES 27 A 455 ILE HIS GLU GLY ASP LEU VAL ALA ALA SER PRO ALA ILE SEQRES 28 A 455 SER ASN ARG ILE PRO GLU ASP PHE PRO ASP PRO HIS ASP SEQRES 29 A 455 PHE VAL PRO ALA ARG TYR GLU GLN PRO ARG GLN GLU ASP SEQRES 30 A 455 LEU LEU ASN ARG TRP THR TRP ILE PRO PHE GLY ALA GLY SEQRES 31 A 455 ARG HIS ARG CYS VAL GLY ALA ALA PHE ALA ILE MET GLN SEQRES 32 A 455 ILE LYS ALA ILE PHE SER VAL LEU LEU ARG GLU TYR GLU SEQRES 33 A 455 PHE GLU MET ALA GLN PRO PRO GLU SER TYR ARG ASN ASP SEQRES 34 A 455 HIS SER LYS MET VAL VAL GLN LEU ALA GLN PRO ALA ALA SEQRES 35 A 455 VAL ARG TYR ARG ARG ARG THR GLY VAL HIS HIS HIS HIS HET HEM A 470 43 HET CII A1450 44 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CII N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL) HETNAM 2 CII PROPYL]CYCLOHEXANECARBOXAMIDE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 CII C17 H25 N3 O2 FORMUL 4 HOH *285(H2 O) HELIX 1 1 HIS A 18 ARG A 23 1 6 HELIX 2 2 ASP A 25 GLY A 38 1 14 HELIX 3 3 GLY A 55 ALA A 65 1 11 HELIX 4 4 GLN A 72 TYR A 76 5 5 HELIX 5 5 TYR A 76 PHE A 78 5 3 HELIX 6 6 MET A 79 GLY A 84 1 6 HELIX 7 7 ARG A 106 ALA A 126 1 21 HELIX 8 8 LEU A 136 ILE A 153 1 18 HELIX 9 9 GLY A 154 ASP A 159 1 6 HELIX 10 10 ASP A 162 GLY A 175 1 14 HELIX 11 11 ASP A 177 VAL A 182 5 6 HELIX 12 12 ILE A 188 ASN A 215 1 28 HELIX 13 13 ASP A 224 VAL A 232 1 9 HELIX 14 14 SER A 242 HIS A 275 1 34 HELIX 15 15 HIS A 275 TYR A 290 1 16 HELIX 16 16 GLY A 291 GLY A 293 5 3 HELIX 17 17 SER A 295 ALA A 300 1 6 HELIX 18 18 ILE A 304 HIS A 318 1 15 HELIX 19 19 SER A 348 ASN A 353 1 6 HELIX 20 20 VAL A 366 GLU A 371 5 6 HELIX 21 21 GLN A 375 ASN A 380 1 6 HELIX 22 22 ALA A 389 ARG A 393 5 5 HELIX 23 23 GLY A 396 GLU A 414 1 19 HELIX 24 24 PRO A 422 TYR A 426 5 5 SHEET 1 AA 5 VAL A 40 LEU A 45 0 SHEET 2 AA 5 LYS A 48 LEU A 53 -1 O LYS A 48 N LEU A 45 SHEET 3 AA 5 LEU A 344 ALA A 347 1 O LEU A 344 N VAL A 51 SHEET 4 AA 5 LEU A 324 ALA A 328 -1 O LEU A 324 N ALA A 347 SHEET 5 AA 5 LEU A 70 ASP A 71 -1 O ASP A 71 N VAL A 327 SHEET 1 AB 3 ALA A 131 ASP A 135 0 SHEET 2 AB 3 ALA A 442 ARG A 447 -1 O VAL A 443 N ILE A 134 SHEET 3 AB 3 TYR A 415 MET A 419 -1 O GLU A 416 N ARG A 446 SHEET 1 AC 2 PHE A 332 VAL A 334 0 SHEET 2 AC 2 HIS A 337 ILE A 339 -1 O HIS A 337 N VAL A 334 SHEET 1 AD 2 ASN A 428 ASP A 429 0 SHEET 2 AD 2 GLN A 436 LEU A 437 -1 O GLN A 436 N ASP A 429 LINK SG CYS A 394 FE HEM A 470 1555 1555 2.34 LINK FE HEM A 470 N1 ACII A1450 1555 1555 2.21 LINK FE HEM A 470 N1 BCII A1450 1555 1555 2.17 CISPEP 1 GLN A 439 PRO A 440 0 3.16 SITE 1 AC1 17 GLN A 72 GLY A 257 THR A 260 PRO A 320 SITE 2 AC1 17 LEU A 324 ARG A 326 PRO A 386 PHE A 387 SITE 3 AC1 17 GLY A 388 HIS A 392 CYS A 394 VAL A 395 SITE 4 AC1 17 GLY A 396 CII A1450 HOH A2169 HOH A2241 SITE 5 AC1 17 HOH A2283 SITE 1 AC2 10 GLN A 72 TYR A 76 MET A 79 PHE A 255 SITE 2 AC2 10 ALA A 256 HIS A 259 HEM A 470 HOH A2059 SITE 3 AC2 10 HOH A2284 HOH A2285 CRYST1 44.745 85.662 110.949 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022349 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011674 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009013 0.00000